Hansa Biopharma AB (publ) (STO: HNSA)

Hansa Biopharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	705	732.06	1,496	651.34	1,139	181.7
Short-Term Investments	-	-	-	237.62	238.14	419.4
Cash & Short-Term Investments	705	732.06	1,496	888.96	1,378	601.09
Cash Growth	-36.06%	-51.07%	68.31%	-35.47%	129.17%	-29.96%
Accounts Receivable	99.33	78.03	42.96	9.71	0.11	0.52
Other Receivables	34.07	15.73	24.22	13.53	7.59	4.73
Receivables	133.4	93.76	67.18	23.24	7.7	5.26
Inventory	2.12	1.51	0.97	0.24	0.1	-
Prepaid Expenses	-	3.06	3.52	3.34	1.66	2.66
Other Current Assets	-	24.76	36.85	26.56	6.43	6.74
Total Current Assets	840.51	855.15	1,605	942.34	1,393	615.74
Property, Plant & Equipment	22.5	27.07	35.84	41.71	9.7	15.14
Other Intangible Assets	166.36	23.17	26.01	28.76	31.41	33.35
Long-Term Deferred Charges	-	112.65	20.85	-	-	-
Total Assets	1,029	1,018	1,687	1,013	1,434	664.24
Accounts Payable	54.93	86.97	62.48	53.36	26.67	50.57
Accrued Expenses	95.69	116.54	100.32	78.22	52.36	31.69
Current Portion of Leases	7.58	7.5	7.17	6.89	4.42	4.63
Current Income Taxes Payable	1.42	1.6	0.6	-	0.13	0.32
Current Unearned Revenue	30.02	41.47	40.43	24.96	17.41	-
Other Current Liabilities	86.17	66.91	53.71	7.79	13.22	7.33
Total Current Liabilities	275.8	320.99	264.71	171.22	114.2	94.54
Long-Term Debt	956.35	844.9	762.6	-	-	-
Long-Term Leases	10.55	14.36	21.33	28.49	0.63	4.83
Long-Term Unearned Revenue	-	-	29.5	47.02	62.03	-
Long-Term Deferred Tax Liabilities	0.36	0.37	0.41	0.43	0.42	0.51
Other Long-Term Liabilities	5.1	5.3	5.95	8.08	15.09	1.55
Total Liabilities	1,248	1,186	1,084	255.24	192.37	101.42
Common Stock	-218.79	55.03	55.03	46.34	45.9	41.45
Additional Paid-In Capital	-	3,083	3,022	2,573	2,509	1,413
Retained Earnings	-	-3,303	-2,471	-1,860	-1,312	-971.82
Treasury Stock	-	-2.36	-2.59	-1.86	-1.42	-1.42
Comprensive Income & Other	-	-0.41	0.01	0.13	-0.14	81.16
Shareholders' Equity	-218.79	-167.88	602.91	757.57	1,242	562.82
Total Liabilities & Equity	1,029	1,018	1,687	1,013	1,434	664.24
Total Debt	974.48	866.77	791.09	35.38	5.05	9.46
Net Cash (Debt)	-269.48	-134.71	705.09	853.58	1,372	591.64
Net Cash Growth	-	-	-17.40%	-37.81%	131.98%	-31.01%
Net Cash Per Share	-4.88	-2.56	15.70	19.19	32.54	14.78
Filing Date Shares Outstanding	67.81	52.67	52.44	44.47	44.47	40.03
Total Common Shares Outstanding	67.81	52.67	52.44	44.47	44.47	40.03
Working Capital	564.72	534.16	1,340	771.12	1,279	521.2
Book Value Per Share	-3.23	-3.19	11.50	17.03	27.93	14.06
Tangible Book Value	-385.16	-191.05	576.9	728.81	1,211	529.47
Tangible Book Value Per Share	-5.68	-3.63	11.00	16.39	27.22	13.23

Source: S&P Capital IQ. Standard template. Financial Sources.